Figure 2

Baseline, 6 and 12 month myocardial T2* values with DFO monotherapy and DFP combination are shown. Myocardial T2* improved in both arms (p = 0.04), with no significant difference between treatments (p = 0.65 for treatment; p = 0.48 for the interaction): improvement with DFP was by 1.5 ms at 6 months and by 1.9 ms at 12 months: with DFP monotherapy this was by 1.1 ms and 1.9 ms respectively.